PMC4359167_01
Graph showing improvement in HbA1c and weight with introduction of liraglutide.
10.1177_2048004015576008-fig1.jpg
PMC4359167_01_10.1177_2048004015576008-fig1.jpg
fig1-2048004015576008
HbA1c dropped further to 6.7% (50 mmol/mol) and in view of her history of recurrent hypoglycaemia, glargine was stopped completely. Her latest review has shown a good therapeutic response to a liraglutide-only regime with her weight reduced to 109.4 kg (BMI 37 kg/m2) and HbA1c of 6.2% (44 mmol/mol) (Figure 1).